Unknown

Dataset Information

0

Sensitive Detection of Therapeutic Efficacy with the ETDRS Diabetic Retinopathy Severity Scale.


ABSTRACT:

Background

The Early Treatment Diabetic Retinopathy Study Diabetic Retinopathy Severity Scale (DRSS) is a standard approach to measure diabetic retinopathy (DR) severity. Many clinical trials evaluating drug intervention for DR rely upon demonstration of a therapeutic effect through measurement of a 2- or 3-step improvement or progression on the DRSS; however, these binary endpoints require a relatively large sample size for a reliable estimate of therapeutic efficacy, especially when the SOC (eg, anti-VEGF) is used as a control. This study was designed to evaluate the sensitivity and statistical efficiency of detecting a drug effect in DR across different DRSS endpoints, and present alternative analytical approaches to enable smaller-size DR trials for detecting a reliable efficacy signal before moving into larger confirmatory DR trials.

Methods

Data from two randomized, double-blinded, controlled Phase III trials, that enrolled patients with decreased vision due to center-involved DME and the presence of macular edema documented on optical coherence tomography and simulated data, were used for this study. Changes in DRSS steps during a 3-month period from patients (n=205) with no active intervention were used to confirm the reliability of DRSS outcomes. A simulation study compared sensitivity and statistical efficiency across different DRSS endpoints.

Results

The standard deviation of step change between baseline and month 3 DRSS across different steps at baseline were all within 1 step, confirming the reliability of DRSS measure by each step. Efficiency of detecting reliable therapeutic efficacy was augmented when treatment effect in improvement and progression was evaluated together; highest sensitivity was observed when change in DRSS steps was used directly as an endpoint.

Conclusion

DRSS step change may provide more robust sensitivity and statistical efficiency. It is therefore a more cost-effective endpoint for the detection of therapeutic efficacy signal in drug discoveries in DR.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC7751690 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sensitive Detection of Therapeutic Efficacy with the ETDRS Diabetic Retinopathy Severity Scale.

Zhang Jiameng J   Strauss Erich C EC  

Clinical ophthalmology (Auckland, N.Z.) 20201216


<h4>Background</h4>The Early Treatment Diabetic Retinopathy Study Diabetic Retinopathy Severity Scale (DRSS) is a standard approach to measure diabetic retinopathy (DR) severity. Many clinical trials evaluating drug intervention for DR rely upon demonstration of a therapeutic effect through measurement of a 2- or 3-step improvement or progression on the DRSS; however, these binary endpoints require a relatively large sample size for a reliable estimate of therapeutic efficacy, especially when th  ...[more]

Similar Datasets

| S-EPMC4209363 | biostudies-literature
| S-EPMC5397990 | biostudies-other
| S-EPMC4830713 | biostudies-literature
| S-EPMC3839118 | biostudies-literature
| S-EPMC8744686 | biostudies-literature
| S-EPMC5341621 | biostudies-literature
| S-EPMC6047149 | biostudies-literature
| S-EPMC5689132 | biostudies-literature
| S-EPMC4271791 | biostudies-literature
| S-EPMC6439787 | biostudies-literature